SOTERA HEALTH COMPANY Deferred Income Tax Expense (Benefit)
SOTERA HEALTH COMPANY (SHC) reported Deferred Income Tax Expense (Benefit) of $13.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-06
- SOTERA HEALTH COMPANY deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $9.63M.
- SOTERA HEALTH COMPANY deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $4.17M.
- SOTERA HEALTH COMPANY deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $16.93M, a 124.54% increase year-over-year.
- SOTERA HEALTH COMPANY deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $8.19M, a 18.06% decline year-over-year.
- SOTERA HEALTH COMPANY deferred income tax expense (benefit) for fiscal 2025 was $22.00K, a 99.77% decline from fiscal 2024.
- SOTERA HEALTH COMPANY deferred income tax expense (benefit) for fiscal 2024 was $9.43M, a 173.50% increase from fiscal 2023.
- SOTERA HEALTH COMPANY deferred income tax expense (benefit) for fiscal 2023 was $3.45M.
- SOTERA HEALTH COMPANY deferred income tax expense (benefit) for fiscal 2022 was -$73.96M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $13.80M 10-Q · filed 2026-08-06 | $30.73M derived: sum of 3 quarters · filed 2026-08-06 | $38.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $4.17M 10-Q · filed 2026-05-05 | $21.10M derived: sum of 2 quarters · filed 2026-05-05 | $29.29M derived: sum of 3 quarters · filed 2026-05-05 | $20.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $16.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $25.12M derived: sum of 2 quarters · filed 2026-02-24 | $16.10M derived: sum of 3 quarters · filed 2026-08-06 | $22.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $8.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$838.00K derived: sum of 2 quarters · filed 2026-08-06 | -$16.91M 10-Q · filed 2025-11-04 | -$9.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$9.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$25.10M 10-Q · filed 2026-08-06 | -$17.56M derived: sum of 3 quarters · filed 2026-08-06 | -$7.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$16.07M 10-Q · filed 2026-05-05 | -$8.53M derived: sum of 2 quarters · filed 2026-05-05 | $1.46M derived: sum of 3 quarters · filed 2026-05-05 | -$3.20M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $7.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $17.53M derived: sum of 2 quarters · filed 2026-02-24 | $12.87M derived: sum of 3 quarters · filed 2026-02-24 | $9.43M 10-K · filed 2026-02-24 |
| 2024-09-30 | $9.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.33M derived: sum of 2 quarters · filed 2025-11-04 | $1.89M 10-Q · filed 2025-11-04 | $2.06M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$8.10M 10-Q · filed 2025-08-08 | -$7.93M derived: sum of 3 quarters · filed 2026-02-24 | -$4.96M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$3.44M 10-Q · filed 2025-05-01 | -$3.28M derived: sum of 2 quarters · filed 2026-02-24 | -$307.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.78M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.13M derived: sum of 2 quarters · filed 2026-02-24 | $5.22M derived: sum of 3 quarters · filed 2026-02-24 | $3.45M 10-K · filed 2026-02-24 |
| 2023-09-30 | $2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $5.05M derived: sum of 2 quarters · filed 2024-11-05 | $3.28M 10-Q · filed 2024-11-05 | -$87.83M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $315.00K 10-Q · filed 2024-08-05 | -$90.80M derived: sum of 3 quarters · filed 2025-02-27 | -$84.06M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$1.77M 10-Q · filed 2024-05-02 | -$92.88M derived: sum of 2 quarters · filed 2025-02-27 | -$86.15M derived: sum of 3 quarters · filed 2025-02-27 | -$81.36M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$91.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$84.38M derived: sum of 2 quarters · filed 2025-02-27 | -$79.59M derived: sum of 3 quarters · filed 2025-02-27 | -$73.96M 10-K · filed 2025-02-27 |
| 2022-09-30 | $6.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $11.52M derived: sum of 2 quarters · filed 2023-11-01 | $17.15M 10-Q · filed 2023-11-01 | $5.31M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $4.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $10.42M 10-Q · filed 2023-08-03 | -$1.43M derived: sum of 3 quarters · filed 2024-02-27 | $3.20M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $5.63M 10-Q · filed 2023-05-03 | -$6.21M derived: sum of 2 quarters · filed 2024-02-27 | -$1.59M derived: sum of 3 quarters · filed 2024-02-27 | $5.55M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$11.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$7.22M derived: sum of 2 quarters · filed 2024-02-27 | -$79.00K derived: sum of 3 quarters · filed 2024-02-27 | -$3.72M 10-K · filed 2024-02-27 |
| 2021-09-30 | $4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $11.77M derived: sum of 2 quarters · filed 2022-11-02 | $8.13M 10-Q · filed 2022-11-02 | -$15.05M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $7.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.50M 10-Q · filed 2022-08-04 | -$19.68M derived: sum of 3 quarters · filed 2023-02-28 | -$11.62M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$3.64M 10-Q · filed 2022-05-05 | -$26.82M derived: sum of 2 quarters · filed 2023-02-28 | -$18.76M derived: sum of 3 quarters · filed 2023-02-28 | -$20.31M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$23.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$15.12M derived: sum of 2 quarters · filed 2023-02-28 | -$16.68M derived: sum of 3 quarters · filed 2023-02-28 | -$23.36M 10-K · filed 2023-02-28 |
| 2020-09-30 | $8.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $6.50M derived: sum of 2 quarters · filed 2021-11-10 | -$178.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$8.24M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$6.68M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$18.99M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |